Roberto Borea, MD· @RobertoBoreaMD · X·· 2 天前评分70
正文 · 原文
Congrats to @drgandara on presenting ASTRIDE at #ESMO26!
Randomized bridging trial in US pts with ES-SCLC: serplulimab vs atezolizumab + chemo
-mOS 12.4 vs 10.2 mo (HR 0.82)
-24-mo OS 32.2% vs 17.6%
-Similar safety
Supports ASTRUM-005 findings in US pts
@myESMO @isliquidbiopsy
27 浏览 · 0 赞 · 1 转发 · 0 回复
会议摘要
来源：Roberto Borea, MD · x.com